Characterization of CD4+ T-cell-dendritic cell interactions during secondary antigen exposure in tolerance and priming.

PubWeight™: 0.92‹?›

🔗 View Article (PMC 2792131)

Published in Immunology on December 01, 2009

Authors

Catherine M Rush1, Owain R Millington, Sharon Hutchison, Karen Bryson, James M Brewer, Paul Garside

Author Affiliations

1: Centre for Biophotonics, Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK.

Articles cited by this

An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J Immunol Methods (1999) 17.06

The B7 family revisited. Annu Rev Immunol (2005) 13.51

Induction by antigen of intrathymic apoptosis of CD4+CD8+TCRlo thymocytes in vivo. Science (1990) 12.13

T-cell priming by dendritic cells in lymph nodes occurs in three distinct phases. Nature (2004) 11.14

Two-photon imaging of lymphocyte motility and antigen response in intact lymph node. Science (2002) 8.94

Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice. Nat Immunol (2005) 7.44

Stromal cell networks regulate lymphocyte entry, migration, and territoriality in lymph nodes. Immunity (2006) 7.22

Differential requirements for survival and proliferation of CD8 naïve or memory T cells. Science (1997) 6.28

Dynamic imaging of T cell-dendritic cell interactions in lymph nodes. Science (2002) 5.61

The duration of antigenic stimulation determines the fate of naive and effector T cells. Immunity (1998) 5.20

Imaging the single cell dynamics of CD4+ T cell activation by dendritic cells in lymph nodes. J Exp Med (2004) 5.08

Reversal of the TCR stop signal by CTLA-4. Science (2006) 4.59

Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement. Immunity (1997) 4.05

T cell repertoire scanning is promoted by dynamic dendritic cell behavior and random T cell motility in the lymph node. Proc Natl Acad Sci U S A (2004) 3.99

Activation of CD25(+)CD4(+) regulatory T cells by oral antigen administration. J Immunol (2001) 3.86

Generation of anergic and potentially immunoregulatory CD25+CD4 T cells in vivo after induction of peripheral tolerance with intravenous or oral antigen. J Immunol (2001) 3.86

Regulatory T cells inhibit stable contacts between CD4+ T cells and dendritic cells in vivo. J Exp Med (2006) 3.57

CD4 effector T cell subsets in the response to influenza: heterogeneity, migration, and function. J Exp Med (2002) 3.28

Distinct T cell dynamics in lymph nodes during the induction of tolerance and immunity. Nat Immunol (2004) 3.25

Stable T cell-dendritic cell interactions precede the development of both tolerance and immunity in vivo. Nat Immunol (2005) 2.89

Naive versus memory CD4 T cell response to antigen. Memory cells are less dependent on accessory cell costimulation and can respond to many antigen-presenting cell types including resting B cells. J Immunol (1994) 2.86

Induction of anergy or active suppression following oral tolerance is determined by antigen dosage. Proc Natl Acad Sci U S A (1994) 2.82

Naive and effector CD4 T cells differ in their requirements for T cell receptor versus costimulatory signals. J Immunol (1996) 2.76

CTLA-4 regulates induction of anergy in vivo. Immunity (2001) 2.39

In situ characterization of CD4+ T cell behavior in mucosal and systemic lymphoid tissues during the induction of oral priming and tolerance. J Exp Med (2005) 2.21

Lymph node topology dictates T cell migration behavior. J Exp Med (2007) 2.19

CD28/B7 regulation of Th1 and Th2 subsets in the development of autoimmune diabetes. Immunity (1996) 2.09

CD4 T cells integrate signals delivered during successive DC encounters in vivo. J Exp Med (2005) 1.99

In situ imaging of the endogenous CD8 T cell response to infection. Science (2007) 1.78

Stop and go traffic to tune T cell responses. Immunity (2004) 1.71

Following the development of a CD4 T cell response in vivo: from activation to memory formation. Immunity (1999) 1.40

T-cell activation occurs simultaneously in local and peripheral lymphoid tissue following oral administration of a range of doses of immunogenic or tolerogenic antigen although tolerized T cells display a defect in cell division. Immunology (2002) 1.29

Tentative T cells: memory cells are quick to respond, but slow to divide. PLoS Pathog (2008) 1.25

Direct measurement of anergy of antigen-specific T cells following oral tolerance induction. J Immunol (1996) 1.22

Malaria impairs T cell clustering and immune priming despite normal signal 1 from dendritic cells. PLoS Pathog (2007) 1.14

Antigen-specific T cell activation and proliferation during oral tolerance induction. J Immunol (1999) 1.13

CTLA-4 disrupts ZAP70 microcluster formation with reduced T cell/APC dwell times and calcium mobilization. Eur J Immunol (2008) 1.04

Orally tolerized T cells are only able to enter B cell follicles following challenge with antigen in adjuvant, but they remain unable to provide B cell help. J Immunol (2002) 1.01

TCR/CD3 mediated stop-signal is decoupled in T-cells from Ctla4 deficient mice. Immunol Lett (2007) 0.99

CTLA-4 expression on antigen-specific cells but not IL-10 secretion is required for oral tolerance. Eur J Immunol (2002) 0.98

CTLA-4 is required for the induction of high dose oral tolerance. Int Immunol (1998) 0.97

Molecular mechanisms of IL-2 gene regulation following costimulation through LFA-1. J Immunol (2001) 0.96

Inverse Rap1 and phospho-ERK expression discriminate the maintenance phase of tolerance and priming of antigen-specific CD4+ T cells in vitro and in vivo. J Immunol (2007) 0.92

Orally tolerized T cells can form conjugates with APCs but are defective in immunological synapse formation. J Immunol (2005) 0.89

Complementary role of CD4+CD25+ regulatory T cells and TGF-beta in oral tolerance. J Leukoc Biol (2005) 0.88

Naive, effector, and memory T lymphocytes efficiently scan dendritic cells in vivo: contact frequency in T cell zones of secondary lymphoid organs does not depend on LFA-1 expression and facilitates survival of effector T cells. J Immunol (2005) 0.88

Induction of bystander suppression by feeding antigen occurs despite normal clonal expansion of the bystander T cell population. J Immunol (2004) 0.88

Roles of cytotoxic T-lymphocyte-associated antigen-4 in the inductive phase of oral tolerance. Immunology (2002) 0.85

Lymphocytes from orally tolerized mice display enhanced susceptibility to death by apoptosis when cultured in the absence of antigen in vitro. Am J Pathol (1996) 0.82

Effect of in vivo administration of anti-CTLA-4 monoclonal antibody and IL-12 on the induction of low-dose oral tolerance. Clin Exp Immunol (2002) 0.78

Articles by these authors

Reversal of the TCR stop signal by CTLA-4. Science (2006) 4.59

Immunomodulatory dendritic cells in intestinal lamina propria. Eur J Immunol (2005) 2.49

In situ characterization of CD4+ T cell behavior in mucosal and systemic lymphoid tissues during the induction of oral priming and tolerance. J Exp Med (2005) 2.21

Analysis of the role of vaccine adjuvants in modulating dendritic cell activation and antigen presentation in vitro. Vaccine (2003) 1.73

T helper (h)1/Th2 and Leishmania: paradox rather than paradigm. Immunol Lett (2005) 1.58

Suppression of adaptive immunity to heterologous antigens during Plasmodium infection through hemozoin-induced failure of dendritic cell function. J Biol (2006) 1.55

In vivo generated Th1 cells can migrate to B cell follicles to support B cell responses. J Immunol (2004) 1.43

T-cell activation occurs simultaneously in local and peripheral lymphoid tissue following oral administration of a range of doses of immunogenic or tolerogenic antigen although tolerized T cells display a defect in cell division. Immunology (2002) 1.29

Antigen depot is not required for alum adjuvanticity. FASEB J (2011) 1.28

Interleukin-18 plays a role in both the alum-induced T helper 2 response and the T helper 1 response induced by alum-adsorbed interleukin-12. Immunology (2003) 1.22

A novel dendritic cell-induced model of erosive inflammatory arthritis: distinct roles for dendritic cells in T cell activation and induction of local inflammation. J Immunol (2002) 1.22

Animal models for arthritis: innovative tools for prevention and treatment. Ann Rheum Dis (2011) 1.20

Mapping pathogenesis of arthritis through small animal models. Rheumatology (Oxford) (2012) 1.18

Identification of a detrimental role for NK cells in pneumococcal pneumonia and sepsis in immunocompromised hosts. Microbes Infect (2005) 1.14

Malaria impairs T cell clustering and immune priming despite normal signal 1 from dendritic cells. PLoS Pathog (2007) 1.14

Plasmacytoid dendritic cells play a key role in promoting atherosclerosis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol (2012) 1.11

Oral tolerance: overview and historical perspectives. Ann N Y Acad Sci (2004) 1.11

The Leishmania mexicana cysteine protease, CPB2.8, induces potent Th2 responses. J Immunol (2003) 1.09

Plasmacytoid dendritic cells regulate breach of self-tolerance in autoimmune arthritis. J Immunol (2009) 1.07

Inducible costimulatory molecule-B7-related protein 1 interactions are important for the clonal expansion and B cell helper functions of naive, Th1, and Th2 T cells. J Immunol (2003) 1.07

TNF-blocking therapies: an alternative mode of action? Trends Immunol (2005) 1.02

Images in cardiovascular medicine. Multiphoton microscopy for 3-dimensional imaging of lymphocyte recruitment into apolipoprotein-E-deficient mouse carotid artery. Circulation (2007) 1.02

In vivo imaging of trypanosome-brain interactions and development of a rapid screening test for drugs against CNS stage trypanosomiasis. PLoS Negl Trop Dis (2013) 1.02

Orally tolerized T cells are only able to enter B cell follicles following challenge with antigen in adjuvant, but they remain unable to provide B cell help. J Immunol (2002) 1.01

Alum increases antigen uptake, reduces antigen degradation and sustains antigen presentation by DCs in vitro. Immunol Lett (2012) 1.01

Abatacept limits breach of self-tolerance in a murine model of arthritis via effects on the generation of T follicular helper cells. J Immunol (2010) 0.99

Host genetic background determines whether IL-18 deficiency results in increased susceptibility or resistance to murine Leishmania major infection. Immunol Lett (2004) 0.98

Efficient priming of CD4+ and CD8+ T cells by DNA vaccination depends on appropriate targeting of sufficient levels of immunologically relevant antigen to appropriate processing pathways. J Immunol (2002) 0.96

Neutralization of interleukin-18 inhibits neointimal formation in a rat model of vascular injury. Circulation (2006) 0.94

Murine neutrophils present Class II restricted antigen. Immunol Lett (2008) 0.94

D6 facilitates cellular migration and fluid flow to lymph nodes by suppressing lymphatic congestion. Blood (2011) 0.93

Inducing experimental arthritis and breaking self-tolerance to joint-specific antigens with trackable, ovalbumin-specific T cells. J Immunol (2004) 0.92

Inverse Rap1 and phospho-ERK expression discriminate the maintenance phase of tolerance and priming of antigen-specific CD4+ T cells in vitro and in vivo. J Immunol (2007) 0.92

Differences in the kinetics, amplitude, and localization of ERK activation in anergy and priming revealed at the level of individual primary T cells by laser scanning cytometry. J Immunol (2004) 0.90

Effect of chromium and cobalt ions on primary human lymphocytes in vitro. J Immunotoxicol (2011) 0.90

The type I IFN system in rheumatoid arthritis. Autoimmunity (2010) 0.90

Identifying the cells breaching self-tolerance in autoimmunity. J Immunol (2010) 0.89

Administration of exogenous interleukin-18 and interleukin-12 prevents the induction of oral tolerance. Immunology (2003) 0.89

ES-62, an immunomodulator secreted by filarial nematodes, suppresses clonal expansion and modifies effector function of heterologous antigen-specific T cells in vivo. J Immunol (2005) 0.89

Modulation of a heterologous immune response by the products of Ascaris suum. Infect Immun (2002) 0.89

Th17 effector cells support B cell responses outside of germinal centres. PLoS One (2012) 0.88

Induction of bystander suppression by feeding antigen occurs despite normal clonal expansion of the bystander T cell population. J Immunol (2004) 0.88

Plasmacytoid dendritic cells: biomarkers or potential therapeutic targets in atherosclerosis? Pharmacol Ther (2012) 0.86

Naive T-cell receptor transgenic T cells help memory B cells produce antibody. Immunology (2006) 0.85

Effect of inducible costimulator blockade on the pathological and protective immune responses induced by the gastrointestinal helminth Trichinella spiralis. Eur J Immunol (2004) 0.85

A detailed characterisation of the distribution and presentation of DNA vaccine encoded antigen. Vaccine (2009) 0.84

In vivo real-time multiphoton imaging of T lymphocytes in the mouse brain after experimental stroke. Stroke (2011) 0.84

Tracking antigen-specific lymphocytes in vivo. Methods Mol Biol (2004) 0.83

A novel method to allow noninvasive, longitudinal imaging of the murine immune system in vivo. Blood (2012) 0.83

Investigating the immunologic effects of CoCr nanoparticles. Clin Orthop Relat Res (2009) 0.83

Complete analysis of the B-cell response to a protein antigen, from in vivo germinal centre formation to 3-D modelling of affinity maturation. Immunology (2003) 0.83

Putative existence of reciprocal dialogue between Tfh and B cells and its impact on infectious and autoimmune disease. Immunol Lett (2011) 0.82

Anatomical and cellular basis of immunity and tolerance in the intestine. J Pediatr Gastroenterol Nutr (2004) 0.82

Analysis of costimulatory molecule expression on antigen-specific T and B cells during the induction of adjuvant-induced Th1 and Th2 type responses. Vaccine (2005) 0.82

Tracking dendritic cells in vivo. Methods Mol Biol (2010) 0.82

OX40 interactions in gastrointestinal nematode infection. Immunology (2006) 0.81

Real-time imaging of the cellular interactions underlying tolerance, priming, and responses to infection. Immunol Rev (2008) 0.81

Tolerant T cells display impaired trafficking ability. Eur J Immunol (2005) 0.81

Investigating the impact of helminth products on immune responsiveness using a TCR transgenic adoptive transfer system. J Immunol (2003) 0.81

Tracking lymphocytes in vivo. Arch Immunol Ther Exp (Warsz) (2004) 0.81

Direct quantitation of T cell signaling by laser scanning cytometry. J Immunol Methods (2005) 0.80

An investigation of the distribution of antigen fed in tolerogenic or immunogenic forms. Immunol Lett (2003) 0.80

Effect of activated antigen-specific B cells on ES-62-mediated modulation of effector function of heterologous antigen-specific T cells in vivo. Immunology (2007) 0.80

Acute inflammatory response to cobalt chromium orthopaedic wear debris in a rodent air-pouch model. J R Soc Interface (2012) 0.80

Universal surface-enhanced Raman tags: individual nanorods for measurements from the visible to the infrared (514-1064 nm). ACS Nano (2014) 0.79

The influence of follicular migration on T-cell differentiation. Immunology (2004) 0.79

Detection of inflammation in vivo by surface-enhanced Raman scattering provides higher sensitivity than conventional fluorescence imaging. Anal Chem (2012) 0.79

Functionalized nanoparticles for bioanalysis by SERRS. Biochem Soc Trans (2009) 0.79

Applying refinement to the use of mice and rats in rheumatoid arthritis research. Inflammopharmacology (2015) 0.78

Liposomal delivery of p-ialB and p-omp25 DNA vaccines improves immunogenicity but fails to provide full protection against B. melitensis challenge. Genet Vaccines Ther (2010) 0.78

BALB/c mice deficient in CD4 T cell IL-4Rα expression control Leishmania mexicana Load although female but not male mice develop a healer phenotype. PLoS Negl Trop Dis (2011) 0.77

Analysis of intracellular enzyme activity by surface enhanced Raman scattering. Analyst (2013) 0.77